Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $45.4 Million - $70.7 Million
-733,069 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $24.1 Million - $35.6 Million
-430,444 Reduced 37.0%
733,069 $46.3 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $56.2 Million - $93.8 Million
1,163,513 New
1,163,513 $91.8 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Jana Partners LLC Portfolio

Follow Jana Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jana Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jana Partners LLC with notifications on news.